Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. May 15, 2016; 8(5): 474-480
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474
Table 1 Characteristics of 17 patients
| Characteristic | Value |
| Mean age (range) | 65 yr (45-76) |
| Men/women (n) | 14/3 |
| ECOG PS (n) | |
| 0 | 14 |
| 1 | 3 |
| 2 | 0 |
| 3 | 0 |
| T stage (n) | |
| T1 | 0 |
| T2 | 2 |
| T3 | 15 |
| T4 | 0 |
| N stage (n) | |
| N0 | 12 |
| N1 | 5 |
| Concurrent chemotherapy (n) | |
| 5-FU/cisplatin | 11 |
| Carboplatin/Taxel | 6 |
| Tumor location: < 35 cm/> 35 cm (n) | 14/3 |
| Mean gross tumor volume (cm3) (range) | 43.7 (33.3-62.4) |
| Mean clinical tumor volume (cm3) (range) | 503.2 (419.3-577.1) |
- Citation: Zeng M, Aguila FN, Patel T, Knapp M, Zhu XQ, Chen XL, Price PD. Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma. World J Gastrointest Oncol 2016; 8(5): 474-480
- URL: https://www.wjgnet.com/1948-5204/full/v8/i5/474.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i5.474